EVOCAL Health is unlocking the human voice as a biomarker for health. The company’s CE-certified, device-agnostic platform enables pharmaceutical companies to collect, monitor, and analyze patient voice data. The vocal biomarker technology provides a comprehensive picture of a patient’s disease progression and response to treatment to better understand cardiovascular, respiratory and neurodegenerative or mental diseases in anon-invasive, convenient, and privacy-compliant way. EVOCAL Health’s vocal biomarker technology provides longitudinal, real-world evidence, enabling patient risk stratification and predictive disease monitoring.
Philip Mertes, CEO and Cofounder - email@example.com